A Decade of Treating ALK-Rearranged Non-Small Cell Lung Cancer in a Lower Middle-Income Country: Changing Patterns and Improving Survival.

Oncol Ther · 2025 · PMC12647493 · PMID 41107702

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

close to significanceno p-value reported

Amongst the variables included in our model, the presence of extrapulmonary metastases significantly worsened progression risk (HR 2.67, 95% CI 1.54–4.64, p = 0.001), while its influence on mortality (HR 1.98, 95% CI 0.99–3.98, p = 0.054) was close to significance.

also in 2,130 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.